Vous êtes ici : AccueilNeuro-DolActualités

  • Sciences Technologies Santé,

Aubin Moutal, Rare autoantibodies betray their targets as drivers of chronic pain

Publié le 29 septembre 2023 Mis à jour le 9 octobre 2023
Aubin Moutal
Aubin Moutal

le 13 octobre 2023

UFR de Medecine et des Professions Paramédicales / UFR de Pharmacie / 28 Place Henri Dunant à Clermont-Ferrand
Faculté de médecine, bâtiment principal, Amphi 6B
Dr Aubin Moutal is a group leader at Saint Louis University, School of Medicine. He focuses on studying rare autoimmune clinical conditions to discover novel proteins involved in the transition to chronic pain. To achieve this goal, his team uses a variety of in vitro and in vivo approaches, from biochemistry and CRISPR to electrophysiology and pain behavior. His
goal is to better understand the synaptic dysregulations underlying the increased spinal neurotransmission in chronic pain conditions.